Loading clinical trials...
Loading clinical trials...
A Multi Centre Open Label Single Therapy Dose Ranging Study to Characterise the Pharmacokinetics & Tolerability of BTDS 5-20 ug/h in Children Who Require Opioid Analgesia for Moderate to Severe Mouth Pain Secondary to Chemotherapy Induced Mucositis.
Conditions
Interventions
Buprenorphine
Locations
2
Denmark
Skejby, Denmark
Dr Howell
Liverpool, United Kingdom
Start Date
February 1, 2010
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
October 24, 2018
Lead Sponsor
Mundipharma Research Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions